Health
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
The Hims app arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its […]
Read More
Athenahealth to offer Abridge’s AI scribe to its network of thousands of doctors
A doctor looks at an AI-generated clinical note. Courtesy of Athenahealth Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians. Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include […]
Read More
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without […]
Read More
Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business
The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City. Carlo Allegri | Reuters Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here’s […]
Read More
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
A popular medical monitor is the latest device produced in China to receive scrutiny for its potential cyber risks. However, it is not the only health device we should be concerned about. Experts say the proliferation of Chinese health-care devices in the U.S. medical system is a cause for concern across the entire ecosystem. The Contec […]
Read More
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
A popular medical monitor is the latest device produced in China to receive scrutiny for its potential cyber risks. However, it is not the only health device we should be concerned about. Experts say the proliferation of Chinese health-care devices in the U.S. medical system is a cause for concern across the entire ecosystem. The Contec […]
Read More
How the FDA’s approval for food additives works, and why experts say a loophole allows companies to bypass it
The U.S. Food and Drug Administration regulates food and health-related products to ensure they’re safe for public health. Today, it’s estimated to oversee 80% of the U.S. food supply. This also places ingredient safety regulations under the FDA’s authority. According to a 1958 law, companies looking to introduce a new food additive into the food […]
Read More
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities […]
Read More
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]
Read More
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the Food and Drug Administration said on Friday. The FDA’s decision will threaten the […]
Read More